Results 71 to 80 of about 5,158 (116)

P990: NF-ΚB AND JAK/STAT PATHWAYS INHIBITION REVERSES FIBROSIS IN A MURINE MODEL OF INFLAMMATION-DRIVEN MYELOFIBROSIS

HemaSphere, 2023
Ernesto José Cuenca Zamora, Pedro Jesús Guijarro Carrillo, María José López Poveda, María Luz Morales Fernández, Maria L Lozano, Rocío González-Conejero, Constantino Martínez, Raúl Teruel Montoya, Francisca Ferrer-Marín   +8 more
doaj   +1 more source

[Suspicion of sarcopenia as a predictor of toxicity in older people with cancer]. [PDF]

Rev Med Inst Mex Seguro Soc
Hernández-García LJ, López-Ahumada M, Mariscal-Ramírez I, Rosas-Carrasco Ó, Espinel-Bermúdez MC, Rodríguez-Ortega HA, Picazo-Turrado JB, Contreras-Haro B.   +7 more
europepmc   +1 more source

Real-world evidence of sacituzumab govitecan in metastatic triple-negative breast cancer: an updated multicenter analysis. [PDF]

ESMO Open
Caputo R, Buono G, Martinelli C, Botticelli A, Caltavituro A, Pantano F, Guarino A, Bonomo MV, Diana A, Carlino F, Rizzo A, Giotta F, Orlando L, Sanò MV, Staropoli N, Von Arx C, Pernice G, Stucci S, Bajardi EA, Ricciardi GR, Turano S, Poggio FB, Cinieri S, Orditura M, Arpino G, Giuliano M, Fabi A, Piezzo M, Del Mastro L, De Laurentiis M.   +29 more
europepmc   +1 more source

[Nested variant of urothelial carcinoma complicated with pulmonary lymphangitis carcinomatosis. Case report]. [PDF]

Rev Med Inst Mex Seguro Soc
Pale-González GA, Díaz-Fuentes H.
europepmc   +1 more source

Uso de inhibidores del receptor del factor de crecimiento epidérmico en estadio precoz: nuestra experiencia clínica

Open Respiratory Archives, 2019
Patricia Cruz Castellanos, Laura Gutiérrez Sainz, Isabel Esteban, Javier de Castro   +3 more
doaj   +1 more source

Correction: A topical nociceutical formulation ameliorates chemotherapy‑induced peripheral neuropathy: a pilot randomized clinical study. [PDF]

Clin Transl Oncol
Servitja S, Castro-Henriques M, Álvarez-Busto I, Díez-Franco C, Medina-Castillo A, Algarra-García MA, López-Miranda E, Lario-Martínez M, Luengo-Alcázar MI, Borregón M, Davó A, Gasull-Delgado A, Roque-García S, Gonzaga-López A, Poveda-Ferriols JM, Pascal S, Mitroi-Marinescu AM, García-Escolano M, Fernández-Carvajal A, Ferrándiz-Huertas C, Ferrer-Montiel A.   +20 more
europepmc   +1 more source

[Integrated care for long-responder women with metastatic breast cancer: Expert opinion for long term management in spain]. [PDF]

Aten Primaria
González V, Martínez Martínez MT, Sanmartín A, de la Haba-Rodríguez JR, Martínez Denaro D, López A.   +5 more
europepmc   +1 more source

Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2- Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial. [PDF]

Clin Cancer Res
Waks AG, Segui E, Li T, Lipsyc-Sharf M, Kallfelz E, DiLullo M, Patel A, Rahman T, Junkins K, Rahee H, Frey AM, Kelly E, Stalteri M, Wrabel E, Williams A, Parsons HA, Poorvu PD, Partridge AH, Abravanel DL, Poorvu N, LeStage B, Sicinski P, Tolaney SM, Wagle N, Tayob N, Shapiro GI.   +25 more
europepmc   +1 more source

Función y Calidad de Vida tras Cáncer de Mama: Límites y Alternativas a los PROMs Clásicos

Revista Brasileira de Cancerologia
La carta al editor comenta y analiza el estudio de Cardoso et al., que evaluó la funcionalidad de las extremidades superiores, la fatiga y la calidad de vida en mujeres sometidas a tratamiento quirúrgico por cáncer de mama en un hospital de referencia ...
Adrián Jesús Barrios-Condori
doaj  

Role of ctDNA in Predicting the Outcome of Patients with Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer Treated with First-line Ribociclib and Letrozole: BioItaLEE Trial. [PDF]

Clin Cancer Res
Bianchini G, Malorni L, Caputo R, Zambelli A, Puglisi F, Bianchi GV, Del Mastro L, Paris I, Montemurro F, Colleoni M, Allegrini G, Tamberi S, Zamagni C, Cazzaniga ME, Orditura M, Guarneri V, Adamo V, Romagnoli E, Valerio MR, Cinieri S, Benelli M, Callari M, Valsecchi D, Castelletti D, Grasso D, Fenderico N, Arpino G, De Laurentiis M.   +27 more
europepmc   +1 more source